Lv1
68 积分 2023-06-26 加入
[The standardization process and clinical challenges in the diagnosis and treatment of IgA nephropathy in China:commentary on the clinical practice guidelines for adult patients with IgA nephropathy and IgA vasculitis-associated nephritis in China (2025)]
5天前
已完结
Atrasentan in Patients with IgA Nephropathy
1个月前
已完结
Atrasentan in Patients with IgA Nephropathy
1个月前
已完结
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
4个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
5个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
5个月前
已完结
二甲双胍控制不佳的中国2型糖尿病患者司美格鲁肽片对比西格列汀的有效性与安全性：PIONEER 12研究中国人群亚组分析
7个月前
已完结
俄罗斯联邦药品流通法
9个月前
已完结
皖公网安备34019202002308
